Serum neurofilaments increase at progressive multifocal leukoencephalopathy onset in natalizumab-treated multiple sclerosis patients. [electronic resource]
- Annals of neurology 04 2019
- 606-610 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1531-8249
10.1002/ana.25437 doi
Adult Biomarkers--blood Cohort Studies Europe--epidemiology Female Follow-Up Studies Humans Immunologic Factors--therapeutic use Leukoencephalopathy, Progressive Multifocal--blood Male Middle Aged Multiple Sclerosis--blood Natalizumab--therapeutic use Neurofilament Proteins--blood Young Adult